Metformin plus lrinotecan in patients with refractorycolorectal cancer: a phase 2 clinical trial
A phase 2 randomized clinical trial of abiraterone plusADT, apalutamide, or abiraterone and apalutamide inpatients with advanced prostate cancer with non-castratetestosterone levels (LACOG 0415)
Brachyury as a potential modulator of androgen receptor activityand a key player in therapy resistance in prostate cancer
An integrated tool for determining the primary originsite of metastatic tumours
Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin
The clinicopathological significance of monocarboxylatetransporters in testicular germ cell tumors
Expression of tyrosine kinase receptor AXL is associated with worseoutcome of metastatic renal cell carcinomas treated with sunitinib
Somatic Copy Number Alterations and Associated Genes inClear-Cell Renal-Cell Carcinoma in Brazilian Patients
Hotspot TERT promoter mutations are rare events in testiculargerm cell tumors
MGMT and CALCA promoter methylation are associated withpoor prognosis in testicular germ cell tumor patients
